View in browser

In a groundbreaking study published on January 18, 2024, in Cancer Discovery, scientists at University of California San Diego School of Medicine leveraged a machine learning algorithm to tackle one of the biggest challenges facing cancer researchers: predicting when cancer will resist chemotherapy. 

The Cancer Day Symposium provides an opportunity for postdoctoral researchers, supported by an NCI-T32 training grant, to invite our favorite influential researchers. We are very excited about the incredible speakers lined up for the 2024 Cancer Day Symposium as their research significantly impacts cancer research at both basic and translational levels. Their diverse expertise includes a novel mass spectrometry-flow cytometry hybrid device (Gary Nolan, Stanford), in vivo imaging (Mikala Egeblad, Johns Hopkins), cutting-edge single molecule imaging (Eli Rothenberg, NYU), innovative strategies for pharmacological targeting including targeted protein degradation (Fleur Ferguson, UCSD), and new mass spectrometry strategies to detect small molecules (Alan Saghatelian, Salk).

The mission of the UC Cancer Consortium (UCCC) Molecular Tumor Board (MTB) is to bring together precision oncology experts from across the UC system to discuss available biomarker-driven therapies for individual patients and ensure awareness of the latest cutting-edge treatment options in cancer care.  

The third virtual session of the 2023-24 UCCC MTB is Tuesday, January 30 at 8 a.m., and will be chaired by UC Davis. Advance registration is required, and participation is limited to UC affiliates with valid UC email addresses.  

Please visit the UCCC MTB website for more information or to register for future meetings. For questions, please contact the UC Cancer Consortium at UCCancer@ucop.edu.  

January 23, 2024 | 12:00

Leichtag Biomedical Research Building Room 107 

January 25, 2024 | 12:00 - 1:00 p.m.

MCC Room 2007

January 29, 2024 | 12:00 - 1:00 p.m.

Comer Commons

January 30, 2024 | 12:00 p.m.

Leichtag Biomedical Research Building Room 107 

Dr. Jing Yang and Dr. Dan Donoghue are opening the call for nominations for the NCI T32 Training Grant in Cancer Cell Signaling & Communication Program. We are looking for outstanding postdoctoral trainees working on cancer research projects from your lab.

All trainees accepted into our program are expected to have strong and diverse backgrounds in cancer biology, biochemistry, molecular and cell biology, chemistry, or bioengineering.

Nominations for the training program must be submitted by January 29, 2024.

Join Drs. Pamela Maher, Claude Sirlin and Carrie House to gain expert advice from UC San Diego, San Diego State University, and Salk Institute for Biological Studies faculty members. All students, postdocs, and junior faculty are welcome to attend!

As a member of the next generation of translational surgeon-scientists, you will undergo rigorous training in three disciplines: 1) the tumor microenvironment; 2) techniques of biobanking; and 3) innovation and entrepreneurship. This is a truly unique, one of a kind training program, and is located at an elite institution with a Training Faculty composed of 18 NIH-funded ($28.1 million per year; $18.5 million in direct costs) Faculty Mentors. Applications must be submitted by March 1, 2024.

The CT2 Program is open to both MDs and PhDs and provides an intensive 2-year period of research and training in the development of novel cancer therapeutics or diagnostics at the Moores Cancer Center. Trainees not only execute a research program under the direction of a member of the faculty of this Comprehensive Cancer Center, but also participate in coursework, seminars, and lectures. Graduates of the program are prepared to transition to leadership roles in cancer therapeutics development in either an academic or commercial environment.

Applications must be submitted by March 15, 2024.

This Notice of Funding Opportunity (NOFO) invites Small Research Grant (R03) applications that propose to study the ethical, legal and social implications (ELSI) of human genetic or genomic research. These applications should be for small, self-contained research projects, such as those that involve single investigators. Of particular interest are projects that propose normative or conceptual analyses, including focused legal, economic, philosophical, anthropological, or historical analyses of new or emerging issues. This mechanism can also be used for the collection of preliminary data and the secondary analysis of existing data. Applications may propose studies using either single or mixed methods. Applied research designed to address ELSI issues in genetics and genomics will also be considered responsive.

Next Deadline: February 19, 2024 (Standard NIH Due Dates Apply)

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications to support the validation of molecular/cellular/imaging markers (referred to as "markers" or "biomarkers") and assays for cancer detection, diagnosis, prognosis, monitoring, and prediction of response or resistance to treatment, as well as markers for cancer prevention and control. This NOFO will support investigator-initiated research for both analytical, and clinical validation of assays to be used in cancer treatment, control, or prevention trials supported by the NCI. This NOFO will also support the validation of pharmacodynamic markers and markers of toxicity. Applicants should have assays that work on human samples and whose importance is well justified for development into clinical assays. 

Next Deadline: February 20, 2024 (Standard NIH Due Dates Apply)

This seed grant funding opportunity supports preliminary findings and exploratory new concepts in early to late- stage gene therapy-related programs. Our aim is to help bridge critical gaps between good ideas and breakthrough discoveries by fostering collaborative interactions to expedite the translation of research into therapeutic treatments. Up to $100K will be awarded per project over a one-year term. 

Deadline: Friday, March 1, 2024

Questions? Contact GTI_admin@health.ucsd.edu

Cell

Kathleen M. Fisch, PhD (Structural and Functional Genomics), Steven L. Gonias, MD, PhD (Solid Tumor Therapeutics), Rob Knight, PhD (Structural and Functional Genomics), Louise C. Laurent, MD (NPA), and Gene W. Yeo, PhD (Structural and Functional Genomics)

Nature Immunology

John T. Chang, MD (Cancer Biology and Signaling), Li-Fan Lu, PhD (Solid Tumor Therapeutics)

Blood

Prashant Mali, PhD (Cancer Biology and Signaling)

PI: Tyler Stewart, MD

NCT: NCT05845814

This intensive summer research experience provides mentoring and research experiences focusing on Biomedical Engineering and Informatics research. We are committed to providing research opportunities to all students, with a special interest in applications from students typically underrepresented within the fields of science, technology, engineering, and mathematics. First-generation college attendees and those attending colleges with limited research opportunities in science, technology, engineering, and mathematics are also encouraged to apply.

Application Deadline: January 26, 2024

Visit Website for More Details

Applications for the 2024 Health Disparities Research Institute (HDRI) will be accepted from February 5 – March 11, 2024. HDRI will take place on August 6 – 9, 2024 and is a unique weeklong program that supports the research career development of promising early-career minority health and health disparities research scientists.

Visit Website for More Details

PRE is a 2-day, in-person event held on May 1-2, 2024, at the National Institutes of Health (NIH). PRE provides Ph.D. candidates the opportunity to explore postdoctoral opportunities and determine if the National Cancer Institute (NCI) is an ideal fit for their professional goals. 

A pre-application webinar for the PRE program will be held on Tuesday, January 23, 2024 from 2:30 - 3:30 p.m. ET. Register Now. Application deadline is Wednesday, February 7, 2024.

Apply Now

The Community Outreach & Engagement team is excited to be continuing its cancer prevention series at the Border View YMCA (3601 Arey Drive, San Diego, CA 92154) next Thursday, January 24th from 10:45-12pm. This workshop is dedicated to raising awareness about cervical cancer and the importance of screening in our Hispanic/Latine community. This free workshop is open to all who are interested in learning more and will include valuable community resources!

Register Now

Happening in one week! The Community Outreach & Engagement will be hosting their 2nd annual Cervical Cancer Awareness Summit on January 29th from 1-2:30pm via zoom.  Hear from experts in the world of cervical cancer, including oncologists, public health professionals and patient advocates, who will share data, best practices and strategies to reduce the cervical cancer burden in our community!

Register Now

Reminder! Please join the Community Outreach & Engagement team for their first CHEC workgroup mixer of the year on January 31st from 12-1:30pm at the Mission Hills Library (215 W Washington St, San Diego, CA 92103). This mixer is a great opportunity to connect with community organizations and network. Light refreshments will be provided to attendees.

RSVP Now

Department of Research Administration

3855 Health Sciences Drive, La Jolla, CA 92037

moorescancercenter.ucsd.edu

Unsubscribe | Privacy Policy | Submit Feedback